Perfusable Microvascular Networks for Acute and Chronic Toxicity Screening
Watch our on-demand webinar with Artur Rodrigues (Early Stage Researcher, MIMETAS) to learn about OrganoAccess, our capabilities in combining complex cell culture in a scalable platform while achieving unprecedented two-month (57-day) stability of perfusable microvascular networks.
In this webinar you’ll learn about:
- Complex Vascular-Stromal Interactions: Self-organizing 3D microvascular networks capturing intricate multicellular and vascular-stromal dynamics in a single integrated platform
- Scalable Architecture without Complexity: Physiologically relevant, gravity-driven perfusion driving unidirectional flow across a complex tissue microenvironment
- Extended Windows for Chronic Toxicology: An 8-week stable culture providing an extended experimental timelines supporting long-term exposure studies with high reproducibility for translational drug discovery
Perfusable Microvascular Networks for Acute and Chronic Toxicity Screening
Perfusable Microvascular Networks for Acute and Chronic Toxicity Screening
To advance drug discovery, more comprehensive 3D in vitro models are needed. Ones that go beyond the traditional compartmentalized setups and mimic different complex cell type interactions by modeling human microvasculature. We introduce OrganoAccess: a robust, self-organizing microvascular platform with gravity-driven unidirectional flow. A stable, scalable, and screening-ready model design integrates immune cells to probe immune responses across different conditions, while the longevity of the vascular bed enables both acute and chronic exposure studies of drug efficacy.
Perfusable Microvascular Networks for Acute and Chronic Toxicity Screening
To advance drug discovery, more comprehensive 3D in vitro models are needed. Ones that go beyond the traditional compartmentalized setups and mimic different complex cell type interactions by modeling human microvasculature. We introduce OrganoAccess: a robust, self-organizing microvascular platform with gravity-driven unidirectional flow. A stable, scalable, and screening-ready model design integrates immune cells to probe immune responses across different conditions, while the longevity of the vascular bed enables both acute and chronic exposure studies of drug efficacy.
Perfusable Microvascular Networks for Acute and Chronic Toxicity Screening
To advance drug discovery, more comprehensive 3D in vitro models are needed. Ones that go beyond the traditional compartmentalized setups and mimic different complex cell type interactions by modeling human microvasculature. We introduce OrganoAccess: a robust, self-organizing microvascular platform with gravity-driven unidirectional flow. A stable, scalable, and screening-ready model design integrates immune cells to probe immune responses across different conditions, while the longevity of the vascular bed enables both acute and chronic exposure studies of drug efficacy.
Perfusable Microvascular Networks for Acute and Chronic Toxicity Screening
To advance drug discovery, more comprehensive 3D in vitro models are needed. Ones that go beyond the traditional compartmentalized setups and mimic different complex cell type interactions by modeling human microvasculature. We introduce OrganoAccess: a robust, self-organizing microvascular platform with gravity-driven unidirectional flow. A stable, scalable, and screening-ready model design integrates immune cells to probe immune responses across different conditions, while the longevity of the vascular bed enables both acute and chronic exposure studies of drug efficacy.
Perfusable Microvascular Networks for Acute and Chronic Toxicity Screening
To advance drug discovery, more comprehensive 3D in vitro models are needed. Ones that go beyond the traditional compartmentalized setups and mimic different complex cell type interactions by modeling human microvasculature. We introduce OrganoAccess: a robust, self-organizing microvascular platform with gravity-driven unidirectional flow. A stable, scalable, and screening-ready model design integrates immune cells to probe immune responses across different conditions, while the longevity of the vascular bed enables both acute and chronic exposure studies of drug efficacy.
Perfusable Microvascular Networks for Acute and Chronic Toxicity Screening
To advance drug discovery, more comprehensive 3D in vitro models are needed. Ones that go beyond the traditional compartmentalized setups and mimic different complex cell type interactions by modeling human microvasculature. We introduce OrganoAccess: a robust, self-organizing microvascular platform with gravity-driven unidirectional flow. A stable, scalable, and screening-ready model design integrates immune cells to probe immune responses across different conditions, while the longevity of the vascular bed enables both acute and chronic exposure studies of drug efficacy.
Perfusable Microvascular Networks for Acute and Chronic Toxicity Screening
To advance drug discovery, more comprehensive 3D in vitro models are needed. Ones that go beyond the traditional compartmentalized setups and mimic different complex cell type interactions by modeling human microvasculature. We introduce OrganoAccess: a robust, self-organizing microvascular platform with gravity-driven unidirectional flow. A stable, scalable, and screening-ready model design integrates immune cells to probe immune responses across different conditions, while the longevity of the vascular bed enables both acute and chronic exposure studies of drug efficacy.
Perfusable Microvascular Networks for Acute and Chronic Toxicity Screening
To advance drug discovery, more comprehensive 3D in vitro models are needed. Ones that go beyond the traditional compartmentalized setups and mimic different complex cell type interactions by modeling human microvasculature. We introduce OrganoAccess: a robust, self-organizing microvascular platform with gravity-driven unidirectional flow. A stable, scalable, and screening-ready model design integrates immune cells to probe immune responses across different conditions, while the longevity of the vascular bed enables both acute and chronic exposure studies of drug efficacy.